The North America Arachidonic Acid Market was valued at US$ 158.06 million in 2022 and is predicted to grow at US$ 190.45 billion by 2028 with an increasing CAGR of 3.83% during 2023-2028.
Arachidonic acid is a long-chain fatty acid that, when coupled with docosahexaenoic acid (DHA), aids in the development of brain cells in infants. The omega 6 fatty acid arachidonic acid is one of the most important. When muscles are damaged, it is stored in the cell membrane and signals adaptive changes. Ingestion of arachidonic acid in the form of pills, injections, and syrups can compensate for the deficiency of arachidonic acid that naturally occurs in the human body. It can be found in a variety of foods, including poultry, meat, fish, eggs, and others. It's also found in the phospholipids of cells near the gallbladder membrane, which is densely packed with the proteins required for phospholipid synthesis.
Arachidonic acid is a polyunsaturated fatty acid that is nearly entirely esterified with phospholipids in secondary glycerol alcohols. Arachidonic acid is found in almost all mammals' phospholipids, and it is an essential fatty acid that cannot be generated within the cell and must be obtained by diet or by lengthening the chain and desaturating another essential fatty acid, linoleic acid. Arachidonic acid metabolism is a mechanism that creates a variety of signaling molecules that are fast-acting and short-lived. Arachidonic acid is released from the set of phospholipids in the cell membrane by cytoplasmic phosphatase A2.
The North America arachidonic acid market is predicted to increase due to rising disposable income, consumption capacity, and consumer awareness of the necessity of preserving nutritional value in the diet. One of the primary aspects driving industry expansion is a growing awareness of parenting products. Manufacturing a product necessitates the use of qualified employees and specialized material handling equipment, which raises production costs. As a result, leading manufacturers are focused on R&D and unique manufacturing technologies to lower production costs while improving product quality and increasing brand value. A diverse value chain of raw material producers, manufacturers, distributors, and end-users distinguishes the industry.
In the ARA industry's value chain, raw material suppliers have become critical. Supplier relevance is expanding, and this is shaping the strategies of key industry participants. Furthermore, increased R&D activity by major businesses in producing new infant goods, as well as increased use of arachidonic acid by manufacturers, is expected to promote worldwide market growth to some extent due to different health benefits. Producing items locally to the end-user reduces shipping costs, minimizes currency volatility, and allows producers to take advantage of local incentives.
Companies from all over the world are increasing their operations in this region, despite the low product penetration rate. In addition, rising demand for arachidonic acid as a component of various food supplements in the pharmaceutical industry is expected to help the global market's growth to some extent. As consumer health awareness grows, so does ARA's demand for dietary supplements. As outdoor sporting activities, such as auto racing and the marathon, become more popular, the risk of bodily damage is expected to rise, thereby driving the market and generating income through higher application. Major companies' increased investment in R&D operations, as well as their approach to profitable product creation, are anticipated to further drive the North America arachidonic acid market growth in the upcoming years.
The high cost of producing arachidonic acid is an important element that is thought to be impeding the worldwide arachidonic acid market's growth. Furthermore, tight product approval requirements are another factor that is expected to hamper the North America arachidonic acid market's growth to some extent.
Based on technology, solvent extraction is anticipated to dominate the North America arachidonic market growth during the forecast period. Solvents were the most popular form segment in 2017, and they are expected to continue to rise in the future due to expanding product application scope. The ingredient is mostly found in infant formula and supplements, which are becoming increasingly popular around the world. Because of the increased profit margins involved, key corporations are concentrating on building innovative solvent-based product portfolios. Over the projected period, the solid form sector is expected to grow at the fastest rate. Product demand in this area is being driven by an increase in the use of sports supplements. Growing customer desire for ARA-based supplements will have a positive impact in the coming years. Increased investment on sports nutrition will drive up product demand even further. Manufacturers are concentrating on generating nutritional goods that comply with the regulations.
The North America Arachidonic Acid (ARA) market accounting is led by the infant formula segment. Polyunsaturated fatty acids have been shown to increase a baby's vision and memory, which is a major market driver. Furthermore, rising regulatory acceptability of oil-based products in newborn nutrition is helping to fuel this expansion. Growing awareness of the product's benefits in baby nutrition has been cited as one of the main reasons for the rise in demand for infant formula. From 2023-2028, the market will be supported by potential applications in health supplements. Major corporations are increasing their R&D expenditures in order to develop innovative uses, such as sports drinks and bodybuilding supplements. Increased demand for health supplements in various locations is expected to open up new opportunities for the industry.
The North America Arachidonic Acid Market Report includes the segmentation of countries:
With a volume share of nearly 40%, North America was the most important regional market. The presence of well-known corporations in North America was credited with this expansion. Because of developing sports and the newborn feeding business, particularly in the United States, and strong consumer purchasing capacity, the region is expected to grow even more throughout the forecast years. This is due to the presence of many firms and intensive R&D efforts with many new patents employing ARA for newborn formula, as well as sports nutrition, and the rising fertility rate in North America, particularly in Mexico, which allows for market expansion for ARA in infant formula. In other North American countries, the current trend of employing ARA to treat diabetes is projected to contribute to market growth.
The covid-19 has significantly affected several industries, which also include the arachidonic acids market. All restaurants and cafes in China have been closed by the Chinese government. Moreover, Covid had affected the supply chain which results in the decline of the market sales.
Key Players listed in the Market:
Major Key Players in the North America Arachidonic Acid Market are
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]